Adaptive Biotechnologies Corporation develops immunosequencing technology to analyze the adaptive immune system. The company offers a proprietary immune medicine platform that translates immune system data for applications in life sciences research, clinical diagnostics, and drug discovery. Adaptive operates in the field of immune medicine, focusing on creating universal diagnostics and leveraging advances in computing to process biological data.
